Mark Witten / en Using predictive biomarkers could improve success rate of new cancer drugs: °µÍřTV study /news/using-predictive-biomarkers-could-improve-success-rate-new-cancer-drugs-u-t-study <span class="field field--name-title field--type-string field--label-hidden">Using predictive biomarkers could improve success rate of new cancer drugs: °µÍřTV study</span> <div class="field field--name-field-featured-picture field--type-image field--label-hidden field__item"> <img loading="eager" srcset="/sites/default/files/styles/news_banner_370/public/national-cancer-institute-9k4Fglw6eFQ-unsplash.jpg?h=afdc3185&amp;itok=LkpLmA37 370w, /sites/default/files/styles/news_banner_740/public/national-cancer-institute-9k4Fglw6eFQ-unsplash.jpg?h=afdc3185&amp;itok=vI8KDA0h 740w, /sites/default/files/styles/news_banner_1110/public/national-cancer-institute-9k4Fglw6eFQ-unsplash.jpg?h=afdc3185&amp;itok=T50Xlvik 1110w" sizes="(min-width:1200px) 1110px, (max-width: 1199px) 80vw, (max-width: 767px) 90vw, (max-width: 575px) 95vw" width="740" height="494" src="/sites/default/files/styles/news_banner_370/public/national-cancer-institute-9k4Fglw6eFQ-unsplash.jpg?h=afdc3185&amp;itok=LkpLmA37" alt="&quot;&quot;"> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span>Christopher.Sorensen</span></span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2021-02-23T12:49:41-05:00" title="Tuesday, February 23, 2021 - 12:49" class="datetime">Tue, 02/23/2021 - 12:49</time> </span> <div class="clearfix text-formatted field field--name-field-cutline-long field--type-text-long field--label-above"> <div class="field__label">Cutline</div> <div class="field__item">A new study by °µÍřTV Mississauga's Jayson Parker provides offers systematic, statistical evidence that biomarkers dramatically improve outcomes when it comes to testing new cancer medicines (photo by National Cancer Institute)</div> </div> <div class="field field--name-field-author-reporters field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/authors-reporters/mark-witten" hreflang="en">Mark Witten</a></div> </div> <div class="field field--name-field-topic field--type-entity-reference field--label-above"> <div class="field__label">Topic</div> <div class="field__item"><a href="/news/topics/breaking-research" hreflang="en">Breaking Research</a></div> </div> <div class="field field--name-field-story-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/tags/biology" hreflang="en">Biology</a></div> <div class="field__item"><a href="/news/tags/cancer" hreflang="en">Cancer</a></div> <div class="field__item"><a href="/news/tags/research-innovation" hreflang="en">Research &amp; Innovation</a></div> <div class="field__item"><a href="/news/tags/u-t-mississauga" hreflang="en">°µÍřTV Mississauga</a></div> </div> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>In recent decades, researchers have made&nbsp;big advances in developing new cancer medicines&nbsp;such as Herceptin, the targeted drug to treat women diagnosed with HER2-positive breast cancer. Yet, despite these successes, cancer remains the second leading cause of death after heart disease and nearly 90 per cent of all cancer drugs entering clinical trial testing fail.</p> <p><img class="migrated-asset" src="/sites/default/files/Jason%20Parker-3.png" alt>Given the millions of lives at stake and the enormous size of the US$200-billion global oncology drug market, the University of Toronto’s&nbsp;<strong>Jayson Parker</strong>&nbsp;asked a simple, but all-important question: “Is there a way to improve clinical trial failure risk?”</p> <p>&nbsp;</p> <p>To find an answer, Parker, an associate professor, teaching stream, of biology at °µÍřTV Mississauga, launched a large-scale research project seven years ago to determine whether the use of predictive biomarkers – which help assess a patient’s likely response to a particular treatment – improved the odds that a new cancer drug would be approved in clinical trials conducted over the past two decades.</p> <p>“We know the high failure rate isn’t because the medicines being tested aren’t working,” says Parker, who is also associate director for the master of biotechnology program at °µÍřTV Mississauga.&nbsp;“We wanted to see if biomarkers improved success rates.”</p> <p>Now, in <a href="https://onlinelibrary.wiley.com/doi/10.1002/cam4.3732">a recent study published&nbsp;in the journal&nbsp;<em>Cancer Medicine</em></a>,&nbsp;Parker and his co-authors provide the first systematic statistical evidence that biomarkers dramatically improve oncology outcomes when it comes to testing new medicines.</p> <p>The new research compared drug approval success rates in biomarker-based clinical trials to outcomes in trials without biomarkers for four types of cancer: breast cancer, melanoma, non-small cell lung cancer&nbsp;and colorectal cancer.</p> <p>“Our overall analysis of these four cancers showed drugs tested in biomarker-based trials were almost five times more likely to receive regulatory approval,” Parker says. “The evidence strongly supports using biomarkers to improve testing outcomes with new cancer medicines.”</p> <p>The greatest benefit was seen in testing new drugs for breast cancer, where biomarker-based trials were 12 times more likely to succeed. There was an eightfold increase in success rates for melanoma drugs that used biomarkers and a sevenfold increase for lung cancer medicines. While drugs for colorectal cancer showed no overall benefit, the researchers say&nbsp;this could change in the future as more biomarkers for colorectal cancer are introduced.</p> <p>Parker evaluated the performance of both well-established and new, exploratory biomarkers. The study’s second key finding revealed that using new biomarkers&nbsp;before they had been properly validated&nbsp;also improved success rates in oncology clinical trials. That is surprising and encouraging, according to Parker, because some experts thought the use of new, unproven biomarkers could potentially increase failure risk.</p> <p>“The data showed exploratory biomarkers still conferred a fourfold benefit compared to no biomarkers. This suggests drug developers can take a chance on new biomarkers because the broad benefits of biomarkers are so strong,” he says.</p> <div class="image-with-caption left"> <p><img class="migrated-asset" src="/sites/default/files/BiomarkersStudents.jpg" alt></p> <p>A pre-COVID photo of some of the students involved in the study. From right: Rohan Tangri, Ashini Weerasinghe, Zain Shah, Kirill Pereverzev and Stephen Mac.</p> </div> <p>Parker’s paper started as a °µÍřTV Mississauga <a href="https://www.utm.utoronto.ca/experience/rop">Research Opportunity Program</a> project in 2014. Seven students have been involved, including four from the <a href="https://www.utm.utoronto.ca/mbiotech/home">MBiotech Program</a>, and they collaborated with an oncologist, computer scientist and data scientist.</p> <p>Data scientist&nbsp;<strong>Nicholas Mitsakakis</strong>&nbsp;applied an innovative machine-learning statistical method, known as multi-state Markov modelling, to analyze 20 years of multi-phase clinical trial data.</p> <p>“It was challenging, but exciting to use this method for the first time in an application for cancer drug testing,” says Mitsakakis, who teaches data science in the MBiotech program and is an adjunct lecturer in biostatistics at °µÍřTV’s Dalla Lana School of Public Health.&nbsp;“The data set was a gold mine.”</p> <p>The study’s robust statistical analysis supports early and aggressive adoption of biomarkers in the design of oncology clinical trials. These new findings matter because oncologists will be more likely to encourage their patients to participate in drug trials that use biomarkers. For the pharmaceutical industry, wider use of biomarkers could reduce drug development costs through better outcomes and the weight of the evidence could help overcome hesitancy or reluctance to use biomarkers because they target sub-populations of patients.</p> <p>Precision medicine is about choosing the right drug for the right group of patients, says Parker, and Biomarkers are a critical tool in precision medicine with the potential to substantially improve success rates in cancer drug development and treatment.</p> <p>“The goal is to get more new cancer medicines approved and medicines that work better in a field with a high risk of failure,” he says. “Using biomarkers in designing clinical trials is a win-win for drug manufacturers, insurers, oncologists&nbsp;and for patients.</p> <p>“The only excuse now for conducting a clinical trial without a biomarker is if there is none available.”</p> </div> <div class="field field--name-field-news-home-page-banner field--type-boolean field--label-above"> <div class="field__label">News home page banner</div> <div class="field__item">Off</div> </div> Tue, 23 Feb 2021 17:49:41 +0000 Christopher.Sorensen 168515 at The kids are gonna be alright /news/kids-are-gonna-be-alright <span class="field field--name-title field--type-string field--label-hidden">The kids are gonna be alright</span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span>sgupta</span></span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2013-05-16T10:58:10-04:00" title="Thursday, May 16, 2013 - 10:58" class="datetime">Thu, 05/16/2013 - 10:58</time> </span> <div class="clearfix text-formatted field field--name-field-cutline-long field--type-text-long field--label-above"> <div class="field__label">Cutline</div> <div class="field__item">°µÍřTV's new program in child and adolescent psychiatry seeks to help youth such as Nick Carveth (photo by Geoff George)</div> </div> <div class="field field--name-field-author-reporters field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/authors-reporters/mark-witten" hreflang="en">Mark Witten</a></div> </div> <div class="field field--name-field-author-legacy field--type-string field--label-above"> <div class="field__label">Author legacy</div> <div class="field__item">Mark Witten</div> </div> <div class="field field--name-field-story-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/tags/more-news" hreflang="en">More News</a></div> <div class="field__item"><a href="/news/tags/medicine" hreflang="en">Medicine</a></div> </div> <div class="field field--name-field-subheadline field--type-string-long field--label-above"> <div class="field__label">Subheadline</div> <div class="field__item">°µÍřTV offers help for children and youth with mental health issues</div> </div> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Nick Carveth was paralyzed by anxiety in his large high school classes. Although bright and articulate, the lanky teen didn’t dare speak up for fear his peers would judge him.</p> <p>Smoking weed helped calm his nerves but before long&nbsp;Carveth was chasing his stress away with chemical drugs such as&nbsp;ecstasy. By age 16, he was carrying a crack pipe in his leather jacket, smoking it just to get through the day.</p> <p>“My drug use was off the charts,” says Carveth, shaking loose a mass of dreadlocks tucked inside a hemp-coloured tam. He tried a handful of abstinence-based drug programs, but they didn’t address his mounting social anxiety and, by age 17, he’d been expelled from two different schools.</p> <p>“I felt alone, like my problems were a life sentence, and there was no way out.”</p> <p>Sadly, Carveth’s struggles are common. Psychiatric disorders are now the number-one reason young people in Canada are hospitalized and why suicide is second only to car accidents as the leading cause of death. Recent high-profile media tragedies involving mentally ill teens — from the suicide of bullied B.C. teenager Amanda Todd to the Christmastime massacre at Sandy Hook — are evidence of the devastation that can happen when kids don’t get the help they need.</p> <p>“Families and youth in crisis often don’t know where to turn. Navigating Ontario’s complex and fragmented youth mental health care system can be daunting. We want to facilitate youth getting the right care at the right time in the right place,” says <strong>Corine Carlisle</strong>, a professor in the University of Toronto’s Department of Psychiatry. “We need to intervene earlier and follow up faster to get youth back on an optimal developmental trajectory. We especially want to provide timely, efficient care so that crises don’t become fatal.”</p> <p>Identifying and treating mental illness early is a critical part of °µÍřTV Medicine’s strategy for improving youth mental health. From backing leading-edge research to developing new, team-based treatment models, the Faculty is helping to ensure teens like Carveth can live meaningful, productive lives — while also reducing the staggering costs to the health care system resulting from disabling, lifelong mental health problems.</p> <p>Training more experts in youth mental health is key. Recently, the Department of Psychiatry introduced a new subspecialty program in child and adolescent psychiatry.</p> <p>“We felt strongly there was a need to focus on underserved areas of psychiatry. The new subspecialty training will increase the number of specialists in child and adolescent psychiatry, making it easier for troubled kids to get the help they need,” says Department Chair <strong>Trevor Young</strong>, noting that historically mental health has been a stigmatized area of medicine and child psychiatry even more so a “poor cousin” within the field.</p> <p>During a two-year program, trainees will serve as consultants to schools, correctional programs, family health teams and community-based children’s mental health agencies, treating kids with mental health problems together with other health professionals. Some of their training will be spent caring for young people with the most complex and difficult problems — such as concurrent substance abuse and mental illness issues — like Carveth’s.</p> <p>But simply training more psychiatric experts is not enough. Research has shown that kids benefit from coordinated care between teams of health professionals — from emergency room staff to family doctors and child psychiatrists. That’s why °µÍřTV, the Centre for Addiction and Mental Health (CAMH) and The Hospital for Sick Children teamed up to form an integrated Child and Youth Mental Health program.</p> <p>The program will help provide more coordinated care for kids with mental illness by integrating child psychiatrists into mixed treatment teams committed to working together, including family physicians, nurse practitioners and other professionals.</p> <p>It will also ensure that scientific research, psychiatric training and clinical care are properly coordinated. Professor <strong>Peter Szatmari</strong>,&nbsp;director of °µÍřTV’s Division of Child and Adolescent Psychiatry who will lead the program, says this structure — where information, expertise and resources are shared — will be critical in tackling the growing needs of children, youth and their families.</p> <p>“One in five children and youth has a mental health problem and only 15 per cent of them receive help from a mental health professional. There’s a huge gap between the need and access to these services,” says Szatmari, chief of the Child and Youth Mental Health Collaborative at the two hospitals. “I see myself as a matchmaker to bring some of the best minds in the field together with a common focus and vision, and come up with solutions. I don’t see child psychiatrists in private practice as a model for today.”</p> <p>That’s why Szatmari plans to build on the joint program with CAMH and SickKids by setting up partnerships with °µÍřTV and other children’s mental health agencies and hospitals affiliated with the Department of Psychiatry.</p> <p>Ramping up research is another priority, says Szatmari, because it identifies weak spots in the system and areas where future efforts should be focused. “A primary goal is to increase research productivity, mentoring the best and brightest so they can be more successful,” says Szatmari, also the director of Research and Training in child and youth psychiatry at °µÍřTV.</p> <p>A good example is recent research by Carlisle, which found that follow-up care for Ontario teens with psychiatric issues is not optimal: less than half of young people aged 15 to 19 hospitalized with a psychiatric diagnosis received follow-up care within a month of being discharged.</p> <p>“Timely aftercare is crucial in maintaining the health of youth with mental illness and avoids future hospitalization,” says Carlisle, the dynamic clinical head of CAMH’s Youth Addiction and Concurrent Disorders Service.</p> <p>Coordinated care is especially critical for youth suffering from multiple issues, which is why, last July, CAMH opened a new inpatient unit offering 24-hour care for young people with concurrent disorders. The first program of its kind in Canada, the 12-bed unit — headed by Carlisle — will treat up to 150 youth from across the province each year.</p> <p>“If you treat substance abuse and mental health issues together, the success rate is much higher,” Carlisle says, noting that of the first 20 youth to complete the program, only one so far has required readmission. “Our inter-professional team is phenomenal at engaging with these youth. These young people come here having given up on themselves. They feel their families, the schools and the justice system have given up on them too. It’s really powerful to see them turn their lives around and regain hope for the future.”</p> <p>For Carveth, it was an outpatient day-treatment program specially designed for teens with mental health and substance abuse problems that helped him regain control over his life. The REACH (Recovery and Education for Adolescents Choosing Health) program, offered by CAMH and the Toronto District School Board, is a harm-reduction program that allows students to work toward high school credits while receiving treatment.</p> <p>“The counsellors are so friendly and empathetic. They meet you where you are at the moment and you get to set your own goals, which helped build momentum in my recovery,” says Carveth, who thrived as part of a small group of six students. The program helped him understand how his drug use was a way of coping with anxiety and an undiagnosed obsessive-compulsive disorder.</p> <p>Thanks to REACH, Carveth dropped his crack cocaine habit, learned to manage his anxiety symptoms and graduated from high school as an Ontario Scholar. Now 23, he’s finishing his third year in the Bachelor of Social Work program at Ryerson University, and passionately interested in counselling youth with mental illness and addictions.</p> <p>“I got the help I needed to face and overcome these issues. That’s given me a career path and an opportunity to help others, one of the most spiritual things in life,” he says.</p> <p>Check out this story and more in the Spring 2013 issue of <a href="http://medicine.utoronto.ca/page/u-t-medicine-magazine"><em>°µÍřTV Medicine Magazine</em></a>.&nbsp;</p> </div> <div class="field field--name-field-news-home-page-banner field--type-boolean field--label-above"> <div class="field__label">News home page banner</div> <div class="field__item">Off</div> </div> <div class="field field--name-field-picpath field--type-string field--label-above"> <div class="field__label">picpath</div> <div class="field__item">sites/default/files/kids-are-alright-13_05_14.jpg</div> </div> Thu, 16 May 2013 14:58:10 +0000 sgupta 5347 at War wounds: the struggle of Mexican journalists /news/war-wounds-struggle-mexican-journalists <span class="field field--name-title field--type-string field--label-hidden">War wounds: the struggle of Mexican journalists</span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span>sgupta</span></span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2013-04-23T05:46:29-04:00" title="Tuesday, April 23, 2013 - 05:46" class="datetime">Tue, 04/23/2013 - 05:46</time> </span> <div class="clearfix text-formatted field field--name-field-cutline-long field--type-text-long field--label-above"> <div class="field__label">Cutline</div> <div class="field__item">Journalists protest the murders and kidnappings of their colleagues in Mexico leaving photos outside the Ministry of the Interior (all photos courtesy Knight Foundation via Flickr)</div> </div> <div class="field field--name-field-author-reporters field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/authors-reporters/mark-witten" hreflang="en">Mark Witten</a></div> </div> <div class="field field--name-field-author-legacy field--type-string field--label-above"> <div class="field__label">Author legacy</div> <div class="field__item">Mark Witten</div> </div> <div class="field field--name-field-topic field--type-entity-reference field--label-above"> <div class="field__label">Topic</div> <div class="field__item"><a href="/news/topics/global-lens" hreflang="en">Global Lens</a></div> </div> <div class="field field--name-field-story-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/tags/features" hreflang="en">Features</a></div> <div class="field__item"><a href="/news/tags/medicine" hreflang="en">Medicine</a></div> <div class="field__item"><a href="/news/tags/law" hreflang="en">Law</a></div> <div class="field__item"><a href="/news/tags/international" hreflang="en">International</a></div> <div class="field__item"><a href="/news/tags/global" hreflang="en">Global</a></div> </div> <div class="field field--name-field-subheadline field--type-string-long field--label-above"> <div class="field__label">Subheadline</div> <div class="field__item">Threats, violence and murder by drug cartels </div> </div> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Over the past decade, University of Toronto psychiatry professor <strong>Anthony Feinstein</strong> has interviewed hundreds of international war correspondents to assess their mental health.</p> <p>Still, nothing prepared him for the gruesome tales he heard from Mexican journalists about drug-related bloodshed on home soil.</p> <p>“It’s a very violent environment. Tens of thousands of Mexicans have died, and the cartels have silenced many journalists through murder and intimidation,” says Feinstein, who is also director of the <a href="http://sunnybrook.ca/content/?page=psychiatry_neuropsychiatry_program">Neuropsychiatry Program </a>at Sunnybrook Health Sciences Centre.</p> <p>Mexico is widely considered one of the most dangerous countries in the world to practice journalism. Last year, more than 170 writers around the world, incuding Neil Gaiman, Margaret Atwood, Chinua Achebe, Colm Toibin and&nbsp;Toni Morrison&nbsp;signed an open letter to the journalists and writers of Mexico "calling out for the killing, the impunity, the intimidation to stop". And<strong>&nbsp;Renu Mandhane</strong>,<strong> </strong>director of the Faculty of Law's<a href="http://www.law.utoronto.ca/programs-centres/programs/international-human-rights-program"> International Human Rights Program<strong>&nbsp;</strong></a>travelled to Mexico as part of an international delegation led by John Ralston Saul asking&nbsp;the government to uphold its legal responsibilities to protect journalists. (<a href="http://www.news.utoronto.ca/staff-member-explores-journalistic-freedom-expression-mexico">Read Mandane's account of the experience</a>.)</p> <p><img alt="crowd of protesters in Mexico" src="/sites/default/files/Mexico-Journalists-2-13_04_23.jpg" style="margin: 10px; width: 400px; float: left; height: 267px">In the first study of its kind, Feinstein found that Mexican reporters covering drug trafficking have as much or more mental distress than war journalists. One in four journalists suffers from mental health problems. Almost half the journalists surveyed know of a colleague murdered by drug cartels and it is not uncommon for&nbsp;reporters' families to be threatened or injured.</p> <p>“They can’t escape the conflict, unlike war correspondents who can get a break,” says Feinstein, whose previous research changed the way big news organizations prepare and care for war correspondents.</p> <p>After revealing that war journalists had rates of posttraumatic stress disorder and depression far exceeding that of the general population, CNN asked Feinstein to lead newsroom educational sessions for journalists about to be deployed and help provide counselling for people returning from the field. He has also helped the BBC, Reuters, CBC, and the Globe and Mail.</p> <p>His website, <a href="http://www.conflict-study.com">www.conflict-study.com</a>, is a resource for journalists suffering from work-related trauma.</p> <p>But Feinstein hasn’t yet persuaded Mexican news organizations to act.</p> <p>“It’s going to be very challenging to convince them to take this issue more seriously,” he says, adding it’s his fervent hope that Mexican journalists get the help they so desperately need.</p> <p>See more stories from Medicine&nbsp;in <a href="http://medicine.utoronto.ca/Spring2013/">the&nbsp;latest issue of °µÍřTV Medicine Magazine</a>.</p> </div> <div class="field field--name-field-news-home-page-banner field--type-boolean field--label-above"> <div class="field__label">News home page banner</div> <div class="field__item">Off</div> </div> <div class="field field--name-field-picpath field--type-string field--label-above"> <div class="field__label">picpath</div> <div class="field__item">sites/default/files/Mexico-Journalists-1-13_04_23.jpg</div> </div> Tue, 23 Apr 2013 09:46:29 +0000 sgupta 5301 at Did diamonds begin on the ancient ocean floor? /news/did-diamonds-begin-ancient-ocean-floor <span class="field field--name-title field--type-string field--label-hidden">Did diamonds begin on the ancient ocean floor?</span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span>sgupta</span></span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2013-04-18T07:08:35-04:00" title="Thursday, April 18, 2013 - 07:08" class="datetime">Thu, 04/18/2013 - 07:08</time> </span> <div class="clearfix text-formatted field field--name-field-cutline-long field--type-text-long field--label-above"> <div class="field__label">Cutline</div> <div class="field__item">Professor Dan Schulze dubbed this diamond "Picasso" for its striking blue luminescence and irregular features</div> </div> <div class="field field--name-field-author-reporters field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/authors-reporters/mark-witten" hreflang="en">Mark Witten</a></div> </div> <div class="field field--name-field-author-legacy field--type-string field--label-above"> <div class="field__label">Author legacy</div> <div class="field__item">Mark Witten</div> </div> <div class="field field--name-field-topic field--type-entity-reference field--label-above"> <div class="field__label">Topic</div> <div class="field__item"><a href="/news/topics/breaking-research" hreflang="en">Breaking Research</a></div> </div> <div class="field field--name-field-story-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/tags/utm" hreflang="en">UTM</a></div> <div class="field__item"><a href="/news/tags/research" hreflang="en">Research</a></div> <div class="field__item"><a href="/news/tags/international" hreflang="en">International</a></div> <div class="field__item"><a href="/news/tags/global" hreflang="en">Global</a></div> <div class="field__item"><a href="/news/tags/faculty-arts-science" hreflang="en">Faculty of Arts &amp; Science</a></div> <div class="field__item"><a href="/news/tags/top-stories" hreflang="en">Top Stories</a></div> </div> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Geology professor <strong>Dan Schulze</strong> calls this singular gem from the remote Guaniamo region of Venezuela the "Picasso" diamond.</p> <p>The blue luminescent, high-resolution image of a diamond formed over a billion years ago reminds him of some paintings from Picasso’s Blue Period. Like a cubist masterpiece, its striking irregular and anomalous features carry timeless secrets and yield new perspectives on life and the Earth’s early history.</p> <p>“A diamond is a time capsule. Anomalies in the chemical signature are the key to understanding the unusual conditions under which some diamonds were formed,” says Schulze, an earth sciences professor in the Department of Chemical and Physical Sciences at the University of Toronto Mississauga.</p> <p>Led by Schulze, an international team of scientists from Australia, Scotland, the United States and Venezuela discovered persuasive new evidence to support the idea that some diamonds, like Picasso, were formed from bacteria or algae on the ancient ocean floor. Their findings suggest these diamonds, known as eclogitic diamonds, originated as organic matter on the ancient sea floor, which was thrust down into the Earth’s mantle by a geological process known as subduction. Attached to ocean floor rock deep beneath the surface, the organic carbon remnants were then transformed by extreme heat and pressure into diamonds.</p> <p>The research is published in the April 2 issue of <em>Geology</em>.</p> <p>Unlike the more common peridotitic diamonds, formed from inorganic carbon found deep in the Earth’s mantle, the origins of eclogitic diamonds have been puzzling and controversial due to differences in their carbon signature.</p> <p>“Because diamonds are impermeable, they preserve inside themselves a record of the chemical and physical conditions that existed as they were formed,” says Schulze, noting that tiny minerals trapped within the diamonds contain telltale clues to help solve the puzzle.</p> <p>In their <em>Geology</em> study, Schulze and his colleagues deciphered this record by analyzing the oxygen composition of tiny garnet and silica grains encapsulated in eclogitic diamonds from mines in Venezuela, Australia and Botswana, and the carbon composition of the diamonds themselves. They observed a pattern of striking anomalies in the chemical signatures of both the mineral grains and diamonds that appear to explain how eclogite diamonds were formed.</p> <p>The silica grains in the Picasso diamond, for example, have a high oxygen composition that matches volcanic rock hydrothermally altered at low temperatures on the ancient sea floor, but is different from typical mantle material.</p> <p>“There is no other place on Earth where you get these values except on the ocean floor,” says Schultze. The diamond itself has a low carbon composition similar to the remains of living organisms.</p> <p>The same pattern of anomalies was consistently found in over 20 diamonds from three continents.</p> <p>“The simplest hypothesis is that the diamonds were formed from subducted organic materials. It’s not just a local phenomenon. This is a geological process that was repeated worldwide in diamonds of different ages from three different locations,” explains Schulze.</p> <p>His research also sheds light on the origins of two famous diamonds in the British Crown Jewels, the Cullinan I and Cullinan II.</p> <p>“There is a high probability that the Cullinan diamond, the largest gem-quality diamond ever found, is an eclogitic diamond made of biogenic material,” he says. “But we’ll never know for sure, as we can’t get the diamonds for study.”</p> <p>Life may have begun on the ancient sea floor and Schulze’s research suggests many of the world’s diamonds originated there too.</p> <p>“There are some people who will never believe this.&nbsp;But these findings will convert more skeptics to a hypothesis that’s getting harder and harder to refute,” he says.</p> </div> <div class="field field--name-field-news-home-page-banner field--type-boolean field--label-above"> <div class="field__label">News home page banner</div> <div class="field__item">Off</div> </div> <div class="field field--name-field-picpath field--type-string field--label-above"> <div class="field__label">picpath</div> <div class="field__item">sites/default/files/Picasso-diamond-13-04-18.jpg</div> </div> Thu, 18 Apr 2013 11:08:35 +0000 sgupta 5292 at